• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

顺势疗法中对映体的应用综述。

A review of use of enantiomers in homeopathy.

作者信息

Kuzeff R M

机构信息

National Institute of Integrative Medicine, 759 Burwood Road, Hawthorn East, Melbourne, VIC 3123, Australia.

出版信息

ISRN Toxicol. 2012 Aug 15;2012:575292. doi: 10.5402/2012/575292. Print 2012.

DOI:10.5402/2012/575292
PMID:23724294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3658497/
Abstract

This paper reviews publications of laboratory experiments using pairs of enantiomers in homeopathy. Many molecules in nature have geometry which enables them to exist as nonsuperimposable mirror images or enantiomers. Modulation of toxicity of such molecules provides possibility for therapeutics, since they target multiple points in biochemical pathways. It was hypothesized that toxicity of a chemical agent could be counteracted by a homeopathic preparation of the enantiomer of the chemical agent (patents applied for: PCT/AU2003/000219-PCT/AU2008/001611). A diverse body of data, including controlled laboratory studies, supports the conclusion that toxicity of optical isomers may be inhibited by homeopathic enantiomer preparations. These data were obtained with minimal or no pretesting to determine optimal test solutions. Inhibition of the excitotoxic neurotransmitter L-glutamic acid with homeopathic preparations of D-glutamic acid indicates the latter may be of use for amelioration of symptoms of disturbances of mood. Similarly, homeopathic preparation of (+)-nicotine may be of use for inhibition of effects of nicotine in tobacco.

摘要

本文综述了顺势疗法中使用对映体对进行实验室实验的相关出版物。自然界中的许多分子具有特定的几何结构，这使得它们能够以不可重叠的镜像形式存在，即对映体。这类分子毒性的调节为治疗提供了可能性，因为它们作用于生化途径中的多个靶点。有人提出假说，化学药剂的毒性可以通过其对映体的顺势疗法制剂来抵消（专利申请号：PCT/AU2003/000219 - PCT/AU2008/001611）。包括对照实验室研究在内的大量数据支持了这样的结论：顺势疗法的对映体制剂可能会抑制光学异构体的毒性。这些数据是在几乎没有或完全没有预先测试以确定最佳测试溶液的情况下获得的。用D - 谷氨酸的顺势疗法制剂抑制兴奋性神经递质L - 谷氨酸，表明后者可能有助于改善情绪障碍的症状。同样，(+)-尼古丁的顺势疗法制剂可能有助于抑制烟草中尼古丁的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/a0edeb921239/ISRN.TOXICOLOGY2012-575292.026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/b9845d051eb2/ISRN.TOXICOLOGY2012-575292.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/d6019615cd93/ISRN.TOXICOLOGY2012-575292.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/f4654d2f9f60/ISRN.TOXICOLOGY2012-575292.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/240bb062e2fa/ISRN.TOXICOLOGY2012-575292.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/4eafc3720562/ISRN.TOXICOLOGY2012-575292.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/03df5ea8e814/ISRN.TOXICOLOGY2012-575292.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/61fd74e8f990/ISRN.TOXICOLOGY2012-575292.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/c7a7a5a87d68/ISRN.TOXICOLOGY2012-575292.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/7854674be7ad/ISRN.TOXICOLOGY2012-575292.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/ff40761d06cc/ISRN.TOXICOLOGY2012-575292.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/6d6f8457a849/ISRN.TOXICOLOGY2012-575292.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/07c7298a1f89/ISRN.TOXICOLOGY2012-575292.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/5a73ed3d4ba0/ISRN.TOXICOLOGY2012-575292.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/d4212f712e73/ISRN.TOXICOLOGY2012-575292.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/6f6a9be23c85/ISRN.TOXICOLOGY2012-575292.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/fc2303766137/ISRN.TOXICOLOGY2012-575292.016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/5638821af457/ISRN.TOXICOLOGY2012-575292.017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/66667d423cad/ISRN.TOXICOLOGY2012-575292.018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/612e23aa5612/ISRN.TOXICOLOGY2012-575292.019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/a93986a96d93/ISRN.TOXICOLOGY2012-575292.020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/c480e30effe9/ISRN.TOXICOLOGY2012-575292.021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/269619624173/ISRN.TOXICOLOGY2012-575292.022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/89deaefefd4c/ISRN.TOXICOLOGY2012-575292.023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/6501754f1b28/ISRN.TOXICOLOGY2012-575292.024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/7469100a6c56/ISRN.TOXICOLOGY2012-575292.025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/a0edeb921239/ISRN.TOXICOLOGY2012-575292.026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/b9845d051eb2/ISRN.TOXICOLOGY2012-575292.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/d6019615cd93/ISRN.TOXICOLOGY2012-575292.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/f4654d2f9f60/ISRN.TOXICOLOGY2012-575292.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/240bb062e2fa/ISRN.TOXICOLOGY2012-575292.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/4eafc3720562/ISRN.TOXICOLOGY2012-575292.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/03df5ea8e814/ISRN.TOXICOLOGY2012-575292.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/61fd74e8f990/ISRN.TOXICOLOGY2012-575292.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/c7a7a5a87d68/ISRN.TOXICOLOGY2012-575292.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/7854674be7ad/ISRN.TOXICOLOGY2012-575292.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/ff40761d06cc/ISRN.TOXICOLOGY2012-575292.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/6d6f8457a849/ISRN.TOXICOLOGY2012-575292.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/07c7298a1f89/ISRN.TOXICOLOGY2012-575292.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/5a73ed3d4ba0/ISRN.TOXICOLOGY2012-575292.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/d4212f712e73/ISRN.TOXICOLOGY2012-575292.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/6f6a9be23c85/ISRN.TOXICOLOGY2012-575292.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/fc2303766137/ISRN.TOXICOLOGY2012-575292.016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/5638821af457/ISRN.TOXICOLOGY2012-575292.017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/66667d423cad/ISRN.TOXICOLOGY2012-575292.018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/612e23aa5612/ISRN.TOXICOLOGY2012-575292.019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/a93986a96d93/ISRN.TOXICOLOGY2012-575292.020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/c480e30effe9/ISRN.TOXICOLOGY2012-575292.021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/269619624173/ISRN.TOXICOLOGY2012-575292.022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/89deaefefd4c/ISRN.TOXICOLOGY2012-575292.023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/6501754f1b28/ISRN.TOXICOLOGY2012-575292.024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/7469100a6c56/ISRN.TOXICOLOGY2012-575292.025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b9c/3658497/a0edeb921239/ISRN.TOXICOLOGY2012-575292.026.jpg

相似文献

1
A review of use of enantiomers in homeopathy.顺势疗法中对映体的应用综述。
ISRN Toxicol. 2012 Aug 15;2012:575292. doi: 10.5402/2012/575292. Print 2012.
2
Physicochemical Investigations of Homeopathic Preparations: A Systematic Review and Bibliometric Analysis-Part 2.顺势疗法制剂的物理化学研究：系统评价和文献计量分析-第 2 部分。
J Altern Complement Med. 2019 Sep;25(9):890-901. doi: 10.1089/acm.2019.0064. Epub 2019 Jul 19.
3
Systematic Review of Plant-Based Homeopathic Basic Research: An Update.植物顺势疗法基础研究的系统评价：最新进展
Homeopathy. 2018 May;107(2):115-129. doi: 10.1055/s-0038-1639580. Epub 2018 Apr 5.
4
Inhibition of (-)-trans-(1S,2S)-U50488 hydrochloride by its enantiomer in white mice -- a placebo-controlled, randomized study.
Forsch Komplementarmed Klass Naturheilkd. 2004 Jun;11(3):144-9. doi: 10.1159/000079443.
5
The use of plant-based bioassays in homeopathic basic research.植物性生物测定法在顺势疗法基础研究中的应用。
Homeopathy. 2015 Oct;104(4):277-82. doi: 10.1016/j.homp.2015.06.009. Epub 2015 Jul 15.
6
Physicochemical Investigations of Homeopathic Preparations: A Systematic Review and Bibliometric Analysis-Part 1.顺势疗法制剂的物理化学研究：系统评价与文献计量分析——第1部分
J Altern Complement Med. 2018 May;24(5):409-421. doi: 10.1089/acm.2017.0249. Epub 2018 Jan 29.
7
Homeopathy for treatment of irritable bowel syndrome.顺势疗法治疗肠易激综合征
Cochrane Database Syst Rev. 2013 Nov 13(11):CD009710. doi: 10.1002/14651858.CD009710.pub2.
8
Homeopathic Dilutions, Hahnemann Principles, and the Solvent Issue: Must We Address Ethanol as a "Homeopathic" or a "Chemical" Issue?顺势疗法稀释法、哈内曼原理与溶剂问题：我们是否必须将乙醇视为一个“顺势疗法”问题还是一个“化学”问题来对待？
Homeopathy. 2018 Feb;107(1):40-44. doi: 10.1055/s-0037-1608898. Epub 2017 Dec 28.
9
Adverse effects of homeopathy, what do we know? A systematic review and meta-analysis of randomized controlled trials.顺势疗法的不良反应，我们了解多少？一项随机对照试验的系统评价和荟萃分析。
Complement Ther Med. 2016 Jun;26:146-63. doi: 10.1016/j.ctim.2016.03.013. Epub 2016 Mar 26.
10
Homeopathy in France in 2011-2012 according to reimbursements in the French national health insurance database (SNIIRAM).2011 - 2012年法国顺势疗法情况，依据法国国家医疗保险数据库（SNIIRAM）中的报销数据。
Fam Pract. 2015 Aug;32(4):442-8. doi: 10.1093/fampra/cmv028. Epub 2015 Apr 28.

本文引用的文献

1
Beyond dopamine: glutamate as a target for future antipsychotics.超越多巴胺：谷氨酸作为未来抗精神病药物的靶点。
ISRN Pharmacol. 2012;2012:427267. doi: 10.5402/2012/427267. Epub 2012 Jul 5.
2
Psychotherapy and medication management strategies for obsessive-compulsive disorder.强迫症的心理治疗和药物管理策略。
Neuropsychiatr Dis Treat. 2011;7:485-94. doi: 10.2147/NDT.S13205. Epub 2011 Aug 23.
3
Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies.精神病学中的顺势疗法治疗：随机安慰剂对照研究的系统评价。
J Clin Psychiatry. 2011 Jun;72(6):795-805. doi: 10.4088/JCP.10r06580.
4
The effect of extremely diluted agitated gibberellic acid (10e-30) on wheat stalk growth--a two researcher pilot study.极稀 gibberellic 酸（10e-30）对小麦茎生长的影响——两位研究者的初步研究。
Complement Ther Med. 2011 Jun;19(3):164-9. doi: 10.1016/j.ctim.2011.03.001. Epub 2011 May 20.
5
Metabotropic glutamate receptors as therapeutic targets for schizophrenia.代谢型谷氨酸受体作为精神分裂症的治疗靶点。
Neuropharmacology. 2012 Mar;62(3):1461-72. doi: 10.1016/j.neuropharm.2011.05.005. Epub 2011 May 19.
6
[The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].[谷氨酸能系统在抑郁症病理生理学及药物治疗中的作用：临床前及临床数据]
Fortschr Neurol Psychiatr. 2011 Apr;79(4):204-12. doi: 10.1055/s-0029-1245770. Epub 2010 Nov 29.
7
Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspective.极端顺势疗法稀释剂保留起始原料：纳米颗粒视角
Homeopathy. 2010 Oct;99(4):231-42. doi: 10.1016/j.homp.2010.05.006.
8
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness.谷氨酸受体在精神疾病的消退和基于消退的治疗中的作用。
Neuropsychopharmacology. 2011 Jan;36(1):274-93. doi: 10.1038/npp.2010.88. Epub 2010 Jul 14.
9
Defining hormesis: evaluation of a complex concentration response phenomenon.定义 hormesis：评价复杂的浓度反应现象。
Int J Toxicol. 2010 May-Jun;29(3):235-46. doi: 10.1177/1091581810363012.
10
Basophil models of homeopathy: a sceptical view.顺势疗法的嗜碱性粒细胞模型：一种怀疑的观点。
Homeopathy. 2010 Jan;99(1):51-6. doi: 10.1016/j.homp.2009.11.005.